Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
June 9, 2015
Patent Application Number
13652965
Date Filed
October 16, 2012
Patent Citations Received
Patent Primary Examiner
Patent abstract
This invention is directed to oligomers composed of 2′-3′-seco-nucleomonomers and nucleotides or modified nucleotides, wherein the oligomer can be a microRNA and include from one to five 2′-3′-seco-nucleomonomers. The oligomers can have a sequence that is complementary to a target nucleotide sequence and be used for affecting the regulation of gene expression. Among other things, the oligomers can provide reduced off target effects.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
